logo
Plus   Neg
Share
Email

Stock Alert: Co-Diagnostics Up 15% On COVID-19 Test Approval

Shares of Co-Diagnostics, Inc. (CODX) jumped 15% on Monday morning after the company announced it received FDA's emergency use authorization for its Covid-19 test.

CODX is currently trading at $27.49, up $3.49 or 14.55%, on the Nasdaq.

Co-Diagnostics said its partner, Clinical Reference Laboratory has FDA Emergency Use Authorization for CRL Rapid Response, a saliva-based COVID-19 test that can be self-administered at home, work or any other setting and then tested using Co-Diagnostics' patented CoPrimer technology.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Discount retailer Dollar General Corp. and supermarket chain Kroger Co. on Thursday reported sharp increases in their quarterly profits on higher sales. While Dollar General's results trounced analysts' estimates, Kroger's earnings beat expectations while revenue fell short. Dollar General's profit for the third quarter surged 57 percent from last year. On January 4, 2021, Discovery plans to launch its new standalone streaming service called Discovery+ which will also offer exclusive streaming access to the BBC's award-winning natural history shows like Planet Earth, Blue Planet, and Frozen Planet. The channel is expected to offer the largest content of real-life entertainment provided by any streaming platform at launch. Boeing Co's 737 MAX, which has been grounded for long following two fatal crashes, conducted its first post-grounding flight with media onboard. American Airlines' 737 MAX flight with around 90 journalists took a 45-minute journey from Dallas, Texas, to Tulsa, Oklahoma. The redesigned jet is scheduled to start its first commercial passenger flight on December 29.
RELATED NEWS
Follow RTT